𝔖 Bobbio Scriptorium
✦   LIBER   ✦

REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells

✍ Scribed by Oosterhoff, Josien K; Penninkhof, Fred; Brinkmann, Albert O; Anton Grootegoed, J; Blok, Leen J

Book ID
110067508
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
247 KB
Volume
22
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Leucinostatin A inhibits prostate cancer
Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells
✍ Manabu Kawada; Hiroyuki Inoue; Shun-Ichi Ohba; Tohru Masuda; Isao Momose; Daishi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 408 KB

## Abstract Targeting stroma in tumor tissues is an attractive new strategy for cancer treatment. We developed __in vitro__ coculture system, in which the growth of human prostate cancer DU‐145 cells is stimulated by prostate stromal cells (PrSC) through insulin‐like growth factor I (IGF‐I). Using

2-methoxyestradiol blocks cell-cycle pro
2-methoxyestradiol blocks cell-cycle progression at G2/M phase and inhibits growth of human prostate cancer cells
✍ Addanki P. Kumar; Gretchen E. Garcia; Thomas J. Slaga 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB 👁 1 views

## Abstract 2‐Methoxyestradiol (2‐ME), an endogenous metabolite of 17β‐estradiol, is present in human blood and urine. Here we show for the first time that 2‐ME significantly inhibited the growth of normal prostate epithelial cells and androgen‐dependent LNCaP and androgen‐independent DU145 prostat